D-β-Hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson diseaseKim Tieu, Serge Przedborski, Vernice Jackson‐Lewis et al.|Journal of Clinical Investigation|2003Cited by 412
D-β-Hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson diseaseKim Tieu, Serge Przedborski, Céline Perier et al.|Journal of Clinical Investigation|2003Cited by 402
S100B is increased in Parkinson’s disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-α pathwayKinnari Sathe, Peter Teismann, Walter Maetzler et al.|Brain|2012Cited by 204
In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizinMatteo Santoro, Peter Teismann, Walter Maetzler et al.|Neurobiology of Disease|2016Cited by 100